chevron_leftBack
As of 16 June 2026, Zhuhai Rundu Pharmaceutical Co., Ltd. has a market cap of $656.79M USD, ranking #13339 globally and #4047 in China.
It ranks #1205 in the Healthcare sector, and #447 in the Drug Manufacturers - General industry.
Key Stats
Market Cap
$656.79MUSD
4.45B CNY
Enterprise Value
$707.64MUSD
4.79B CNY
Revenue (TTM)
$175.71MUSD
1.19B CNY
EBITDA (TTM)
$17.31MUSD
117.17M CNY
Net Income (TTM)
-$7.68MUSD
-51.99M CNY
EBITDA Margin
9.8%
Profit Margin
-4.4%
PS Ratio
3.7
PB Ratio
4.2
EV/EBITDA
39.9
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Jie Liu
open_in_new
Employees
1,985
Founded
1999
Website
rdpharma.cn
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| -0.5% | 7.3% | -18% | -3.2% | 2.4% | 14% |
News
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
002923
珠海润都制药股份有限公司 Class A
ISIN: CNE1000033G8
Shares Out.:
Shares Outstanding:
334.893M1
Shares Float:
252.033M2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
13.22 CNY |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Zhuhai Rundu Pharmaceutical Co., Ltd.
Zhuhai Rundu Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of chemical pharmaceutical preparations, APIs, and pharmaceutical intermediates in China and internationally. It offers FDF for cardiovascular; and pellets for excipient, antiulcerative, diabetes drug, anti-inflammatory, and anti-anginals. The company is also involved in the process development, quality research, and registration of chemical drugs. In addition, it provides branding services of drug products, as well as academic services. The company was founded in 1999 and is headquartered in Zhuhai, China.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
SSE: 600276
|
$53.89B
8K%
364.89B CNY
|
44.9
|
|
SSE: 603259
|
$49.67B
7K%
336.36B CNY
|
17.2
|
|
SHEK: 3692
|
$28.52B
4K%
223.48B HKD
|
35.7
|
|
SHEK: 1801
|
$18.8B
3K%
147.32B HKD
|
162.3
|
|
SSE: 688506
|
$16.52B
2K%
111.89B CNY
|
-
|
|
SHEK: 9926
|
$16.01B
2K%
125.46B HKD
|
-
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NYSE: LLY
|
$761.68B
116K%
|
38.1
|
|
NYSE: JNJ
|
$547.28B
83K%
|
26.4
|
|
NYSE: ABBV
|
$360.63B
55K%
|
97.4
|
|
SIX: RO
|
$322.73B
49K%
256.25B CHF
|
19.9
|
|
LSE: AZN
|
$289.3B
44K%
215.59B GBP
|
27.6
|
|
SIX: NOVN
|
$275.68B
42K%
218.9B CHF
|
20.5
|
chevron_leftBack